Stock Scorecard
Stock Summary for Prestige Consumer Healthcare Inc (PBH) - $74.12 as of 9/16/2024 2:09:32 PM EST
Total Score
11 out of 30
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for PBH
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for PBH
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for PBH
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for PBH
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Latest News for for PBH
Financial Details for PBH
Company Overview |
|
|---|---|
| Ticker | PBH |
| Company Name | Prestige Consumer Healthcare Inc |
| Country | USA |
| Description | Prestige Consumer Healthcare Inc., develops, manufactures, markets, distributes and sells over-the-counter (OTC) healthcare products in the United States and internationally. The company is headquartered in Tarrytown, New York. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 6/30/2024 |
| Next Earnings Date | 10/31/2024 |
Stock Price History |
|
| Last Day Price | 74.12 |
| Last Day Price Updated | 9/16/2024 2:09:32 PM EST |
| Last Day Volume | 164,257 |
| Average Daily Volume | 240,969 |
| 52-Week High | 75.80 |
| 52-Week Low | 56.34 |
| Last Price to 52 Week Low | 31.56% |
Valuation Measures |
|
| Trailing PE | 18.12 |
| Industry PE | 35.21 |
| Sector PE | 82.23 |
| 5-Year Average PE | 16.65 |
| Free Cash Flow Ratio | 107.42 |
| Industry Free Cash Flow Ratio | 13.26 |
| Sector Free Cash Flow Ratio | 32.42 |
| Current Ratio Most Recent Quarter | 3.23 |
| Total Cash Per Share | 0.69 |
| Book Value Per Share Most Recent Quarter | 33.92 |
| Price to Book Ratio | 2.15 |
| Industry Price to Book Ratio | 6.09 |
| Sector Price to Book Ratio | 22.15 |
| Price to Sales Ratio Twelve Trailing Months | 3.30 |
| Industry Price to Sales Ratio Twelve Trailing Months | 7.04 |
| Sector Price to Sales Ratio Twelve Trailing Months | 6.51 |
Share Statistics |
|
| Total Shares Outstanding | 49,557,400 |
| Market Capitalization | 3,673,194,488 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 12/27/2013 |
| Last Dividend Amount | 0.00 |
| Current Dividend Amount | 0.00 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 5.01% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | -7.50% |
| Annual Earnings Growth | 354.34% |
| Reported EPS 12 Trailing Months | 4.09 |
| Reported EPS Past Year | 0.90 |
| Reported EPS Prior Year | 4.17 |
| Net Income Twelve Trailing Months | 205,131,000 |
| Net Income Past Year | 209,339,000 |
| Net Income Prior Year | -82,306,000 |
| Quarterly Revenue Growth YOY | -4.40% |
| 5-Year Revenue Growth | 2.89% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 34,256,000 |
| Total Cash Past Year | 46,469,000 |
| Total Cash Prior Year | 58,489,000 |
| Net Cash Position Most Recent Quarter | -1,056,951,000 |
| Net Cash Position Past Year | -1,079,335,000 |
| Long Term Debt Past Year | 1,125,804,000 |
| Long Term Debt Prior Year | 1,345,788,000 |
| Total Debt Most Recent Quarter | 1,091,207,000 |
| Equity to Debt Ratio Past Year | 0.60 |
| Equity to Debt Ratio Most Recent Quarter | 0.61 |
| Total Stockholder Equity Past Year | 1,655,084,000 |
| Total Stockholder Equity Prior Year | 1,447,084,000 |
| Total Stockholder Equity Most Recent Quarter | 1,680,767,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 246,390,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 4.97 |
| Free Cash Flow Past Year | 239,376,000 |
| Free Cash Flow Prior Year | 221,932,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.92 |
| MACD Signal | 1.13 |
| 20-Day Bollinger Lower Band | 62.59 |
| 20-Day Bollinger Middle Band | 69.04 |
| 20-Day Bollinger Upper Band | 75.49 |
| Beta | 0.48 |
| RSI | 47.30 |
| 50-Day SMA | 65.77 |
| 150-Day SMA | 60.89 |
| 200-Day SMA | 57.46 |
System |
|
| Modified | 9/14/2024 10:18:21 AM EST |